EUROPEAN JOURNAL OF CANCER-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：癌症;肿瘤;临床 经验分享：做的自己的测序数据➕公共数据库的分析， Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20，一周了还在编辑手里，急死了，(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157084, encodeId=ab09215e0844c, content=9月5日投稿， 9月8日 w i t h e d i t o r，当天 d e c i s i o n i n p r o c e s s 是不是直接被拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fade2534638, createdName=lieju2, createdTime=Mon Sep 11 08:44:14 CST 2023, time=2023-09-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=946016, encodeId=6bad94601674, content=审稿速度:2.0 经验分享：2021-01-29提交 2021-02-01 with editor 2021-03-01 decision in process 中间没有 undrer review，网上询问网友的结果是多半悲剧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/c43b318bec32425a9676f05399c0cd55/11d43e45561e4c748a631fc4a900607e.jpg, createdBy=5bff5319966, createdName=mmz2101863, createdTime=Sat Mar 06 19:31:45 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：投稿2天后with editor，26天后decision in prosess，大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2114665, encodeId=31b021146654c, content=偏重的研究方向：肿瘤化疗 经验分享：当天with editor，两周多后直接Decision in Process，感觉要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Wed Feb 15 01:50:22 CST 2023, time=2023-02-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2091936, encodeId=f0a2209193669, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：投稿当天under review 一个月reviews completed 十天后decision in progress 两天后reject 拒绝的很干脆（伤心流泪猫猫头.jpg）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=519d8123215, createdName=ms2000000001186103, createdTime=Wed Oct 05 17:30:21 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1225100, encodeId=2e8412251000f, content=with editor是还没找到编辑呢吗？要多久啊，我这一周多了还没信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Tue Jun 07 23:40:09 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207583, encodeId=c1e9120e583f8, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：with editor一周多了，是不是投搞时候要选择一个编辑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Thu Mar 31 16:38:30 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193646, encodeId=95b5119364659, content=2月10号投稿，2月14号with editor,2月14号当天decision in process，中间没有 undrer review，是不是要被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375f6502182, createdName=ms1000000321963424, createdTime=Tue Feb 15 16:29:09 CST 2022, time=2022-02-15, status=1, ipAttribution=)]

2022-02-20 一只虫虫

审稿速度:4.0 | 投稿命中率:25.0
偏重的研究方向：癌症;肿瘤;临床
经验分享：做的自己的测序数据➕公共数据库的分析， Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20，一周了还在编辑手里，急死了，(¬_¬)后续进展会在评论里持续更新

106 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：癌症;肿瘤;临床 经验分享：做的自己的测序数据➕公共数据库的分析， Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20，一周了还在编辑手里，急死了，(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157084, encodeId=ab09215e0844c, content=9月5日投稿， 9月8日 w i t h e d i t o r，当天 d e c i s i o n i n p r o c e s s 是不是直接被拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fade2534638, createdName=lieju2, createdTime=Mon Sep 11 08:44:14 CST 2023, time=2023-09-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=946016, encodeId=6bad94601674, content=审稿速度:2.0 经验分享：2021-01-29提交 2021-02-01 with editor 2021-03-01 decision in process 中间没有 undrer review，网上询问网友的结果是多半悲剧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/c43b318bec32425a9676f05399c0cd55/11d43e45561e4c748a631fc4a900607e.jpg, createdBy=5bff5319966, createdName=mmz2101863, createdTime=Sat Mar 06 19:31:45 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：投稿2天后with editor，26天后decision in prosess，大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2114665, encodeId=31b021146654c, content=偏重的研究方向：肿瘤化疗 经验分享：当天with editor，两周多后直接Decision in Process，感觉要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Wed Feb 15 01:50:22 CST 2023, time=2023-02-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2091936, encodeId=f0a2209193669, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：投稿当天under review 一个月reviews completed 十天后decision in progress 两天后reject 拒绝的很干脆（伤心流泪猫猫头.jpg）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=519d8123215, createdName=ms2000000001186103, createdTime=Wed Oct 05 17:30:21 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1225100, encodeId=2e8412251000f, content=with editor是还没找到编辑呢吗？要多久啊，我这一周多了还没信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Tue Jun 07 23:40:09 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207583, encodeId=c1e9120e583f8, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：with editor一周多了，是不是投搞时候要选择一个编辑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Thu Mar 31 16:38:30 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193646, encodeId=95b5119364659, content=2月10号投稿，2月14号with editor,2月14号当天decision in process，中间没有 undrer review，是不是要被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375f6502182, createdName=ms1000000321963424, createdTime=Tue Feb 15 16:29:09 CST 2022, time=2022-02-15, status=1, ipAttribution=)]

2023-09-11 lieju2 来自上海

9月5日投稿， 9月8日 w i t h e d i t o r，当天 d e c i s i o n i n p r o c e s s 是不是直接被拒了？

40 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：癌症;肿瘤;临床 经验分享：做的自己的测序数据➕公共数据库的分析， Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20，一周了还在编辑手里，急死了，(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157084, encodeId=ab09215e0844c, content=9月5日投稿， 9月8日 w i t h e d i t o r，当天 d e c i s i o n i n p r o c e s s 是不是直接被拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fade2534638, createdName=lieju2, createdTime=Mon Sep 11 08:44:14 CST 2023, time=2023-09-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=946016, encodeId=6bad94601674, content=审稿速度:2.0 经验分享：2021-01-29提交 2021-02-01 with editor 2021-03-01 decision in process 中间没有 undrer review，网上询问网友的结果是多半悲剧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/c43b318bec32425a9676f05399c0cd55/11d43e45561e4c748a631fc4a900607e.jpg, createdBy=5bff5319966, createdName=mmz2101863, createdTime=Sat Mar 06 19:31:45 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：投稿2天后with editor，26天后decision in prosess，大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2114665, encodeId=31b021146654c, content=偏重的研究方向：肿瘤化疗 经验分享：当天with editor，两周多后直接Decision in Process，感觉要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Wed Feb 15 01:50:22 CST 2023, time=2023-02-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2091936, encodeId=f0a2209193669, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：投稿当天under review 一个月reviews completed 十天后decision in progress 两天后reject 拒绝的很干脆（伤心流泪猫猫头.jpg）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=519d8123215, createdName=ms2000000001186103, createdTime=Wed Oct 05 17:30:21 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1225100, encodeId=2e8412251000f, content=with editor是还没找到编辑呢吗？要多久啊，我这一周多了还没信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Tue Jun 07 23:40:09 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207583, encodeId=c1e9120e583f8, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：with editor一周多了，是不是投搞时候要选择一个编辑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Thu Mar 31 16:38:30 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193646, encodeId=95b5119364659, content=2月10号投稿，2月14号with editor,2月14号当天decision in process，中间没有 undrer review，是不是要被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375f6502182, createdName=ms1000000321963424, createdTime=Tue Feb 15 16:29:09 CST 2022, time=2022-02-15, status=1, ipAttribution=)]

2021-03-06 mmz2101863

审稿速度:2.0
经验分享：2021-01-29提交
2021-02-01 with editor
2021-03-01 decision in process
中间没有 undrer review，网上询问网友的结果是多半悲剧。

102 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：癌症;肿瘤;临床 经验分享：做的自己的测序数据➕公共数据库的分析， Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20，一周了还在编辑手里，急死了，(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157084, encodeId=ab09215e0844c, content=9月5日投稿， 9月8日 w i t h e d i t o r，当天 d e c i s i o n i n p r o c e s s 是不是直接被拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fade2534638, createdName=lieju2, createdTime=Mon Sep 11 08:44:14 CST 2023, time=2023-09-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=946016, encodeId=6bad94601674, content=审稿速度:2.0 经验分享：2021-01-29提交 2021-02-01 with editor 2021-03-01 decision in process 中间没有 undrer review，网上询问网友的结果是多半悲剧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/c43b318bec32425a9676f05399c0cd55/11d43e45561e4c748a631fc4a900607e.jpg, createdBy=5bff5319966, createdName=mmz2101863, createdTime=Sat Mar 06 19:31:45 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：投稿2天后with editor，26天后decision in prosess，大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2114665, encodeId=31b021146654c, content=偏重的研究方向：肿瘤化疗 经验分享：当天with editor，两周多后直接Decision in Process，感觉要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Wed Feb 15 01:50:22 CST 2023, time=2023-02-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2091936, encodeId=f0a2209193669, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：投稿当天under review 一个月reviews completed 十天后decision in progress 两天后reject 拒绝的很干脆（伤心流泪猫猫头.jpg）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=519d8123215, createdName=ms2000000001186103, createdTime=Wed Oct 05 17:30:21 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1225100, encodeId=2e8412251000f, content=with editor是还没找到编辑呢吗？要多久啊，我这一周多了还没信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Tue Jun 07 23:40:09 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207583, encodeId=c1e9120e583f8, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：with editor一周多了，是不是投搞时候要选择一个编辑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Thu Mar 31 16:38:30 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193646, encodeId=95b5119364659, content=2月10号投稿，2月14号with editor,2月14号当天decision in process，中间没有 undrer review，是不是要被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375f6502182, createdName=ms1000000321963424, createdTime=Tue Feb 15 16:29:09 CST 2022, time=2022-02-15, status=1, ipAttribution=)]

2023-07-28 ms7000000964395486 来自浙江省

审稿速度:6.0 | 投稿命中率:5.0
偏重的研究方向：肿瘤
经验分享：投稿2天后with editor，26天后decision in prosess，大概率是凉了。

47 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：癌症;肿瘤;临床 经验分享：做的自己的测序数据➕公共数据库的分析， Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20，一周了还在编辑手里，急死了，(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157084, encodeId=ab09215e0844c, content=9月5日投稿， 9月8日 w i t h e d i t o r，当天 d e c i s i o n i n p r o c e s s 是不是直接被拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fade2534638, createdName=lieju2, createdTime=Mon Sep 11 08:44:14 CST 2023, time=2023-09-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=946016, encodeId=6bad94601674, content=审稿速度:2.0 经验分享：2021-01-29提交 2021-02-01 with editor 2021-03-01 decision in process 中间没有 undrer review，网上询问网友的结果是多半悲剧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/c43b318bec32425a9676f05399c0cd55/11d43e45561e4c748a631fc4a900607e.jpg, createdBy=5bff5319966, createdName=mmz2101863, createdTime=Sat Mar 06 19:31:45 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：投稿2天后with editor，26天后decision in prosess，大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2114665, encodeId=31b021146654c, content=偏重的研究方向：肿瘤化疗 经验分享：当天with editor，两周多后直接Decision in Process，感觉要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Wed Feb 15 01:50:22 CST 2023, time=2023-02-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2091936, encodeId=f0a2209193669, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：投稿当天under review 一个月reviews completed 十天后decision in progress 两天后reject 拒绝的很干脆（伤心流泪猫猫头.jpg）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=519d8123215, createdName=ms2000000001186103, createdTime=Wed Oct 05 17:30:21 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1225100, encodeId=2e8412251000f, content=with editor是还没找到编辑呢吗？要多久啊，我这一周多了还没信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Tue Jun 07 23:40:09 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207583, encodeId=c1e9120e583f8, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：with editor一周多了，是不是投搞时候要选择一个编辑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Thu Mar 31 16:38:30 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193646, encodeId=95b5119364659, content=2月10号投稿，2月14号with editor,2月14号当天decision in process，中间没有 undrer review，是不是要被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375f6502182, createdName=ms1000000321963424, createdTime=Tue Feb 15 16:29:09 CST 2022, time=2022-02-15, status=1, ipAttribution=)]

2023-02-15 ms5000000259255905 来自北京

偏重的研究方向：肿瘤化疗
经验分享：当天with editor，两周多后直接Decision in Process，感觉要凉了

56 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：癌症;肿瘤;临床 经验分享：做的自己的测序数据➕公共数据库的分析， Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20，一周了还在编辑手里，急死了，(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157084, encodeId=ab09215e0844c, content=9月5日投稿， 9月8日 w i t h e d i t o r，当天 d e c i s i o n i n p r o c e s s 是不是直接被拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fade2534638, createdName=lieju2, createdTime=Mon Sep 11 08:44:14 CST 2023, time=2023-09-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=946016, encodeId=6bad94601674, content=审稿速度:2.0 经验分享：2021-01-29提交 2021-02-01 with editor 2021-03-01 decision in process 中间没有 undrer review，网上询问网友的结果是多半悲剧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/c43b318bec32425a9676f05399c0cd55/11d43e45561e4c748a631fc4a900607e.jpg, createdBy=5bff5319966, createdName=mmz2101863, createdTime=Sat Mar 06 19:31:45 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：投稿2天后with editor，26天后decision in prosess，大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2114665, encodeId=31b021146654c, content=偏重的研究方向：肿瘤化疗 经验分享：当天with editor，两周多后直接Decision in Process，感觉要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Wed Feb 15 01:50:22 CST 2023, time=2023-02-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2091936, encodeId=f0a2209193669, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：投稿当天under review 一个月reviews completed 十天后decision in progress 两天后reject 拒绝的很干脆（伤心流泪猫猫头.jpg）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=519d8123215, createdName=ms2000000001186103, createdTime=Wed Oct 05 17:30:21 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1225100, encodeId=2e8412251000f, content=with editor是还没找到编辑呢吗？要多久啊，我这一周多了还没信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Tue Jun 07 23:40:09 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207583, encodeId=c1e9120e583f8, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：with editor一周多了，是不是投搞时候要选择一个编辑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Thu Mar 31 16:38:30 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193646, encodeId=95b5119364659, content=2月10号投稿，2月14号with editor,2月14号当天decision in process，中间没有 undrer review，是不是要被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375f6502182, createdName=ms1000000321963424, createdTime=Tue Feb 15 16:29:09 CST 2022, time=2022-02-15, status=1, ipAttribution=)]

2022-10-05 ms2000000001186103

审稿速度:1.0
偏重的研究方向：肿瘤
经验分享：投稿当天under review 一个月reviews completed 十天后decision in progress 两天后reject 拒绝的很干脆（伤心流泪猫猫头.jpg）

77 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：癌症;肿瘤;临床 经验分享：做的自己的测序数据➕公共数据库的分析， Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20，一周了还在编辑手里，急死了，(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157084, encodeId=ab09215e0844c, content=9月5日投稿， 9月8日 w i t h e d i t o r，当天 d e c i s i o n i n p r o c e s s 是不是直接被拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fade2534638, createdName=lieju2, createdTime=Mon Sep 11 08:44:14 CST 2023, time=2023-09-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=946016, encodeId=6bad94601674, content=审稿速度:2.0 经验分享：2021-01-29提交 2021-02-01 with editor 2021-03-01 decision in process 中间没有 undrer review，网上询问网友的结果是多半悲剧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/c43b318bec32425a9676f05399c0cd55/11d43e45561e4c748a631fc4a900607e.jpg, createdBy=5bff5319966, createdName=mmz2101863, createdTime=Sat Mar 06 19:31:45 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：投稿2天后with editor，26天后decision in prosess，大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2114665, encodeId=31b021146654c, content=偏重的研究方向：肿瘤化疗 经验分享：当天with editor，两周多后直接Decision in Process，感觉要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Wed Feb 15 01:50:22 CST 2023, time=2023-02-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2091936, encodeId=f0a2209193669, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：投稿当天under review 一个月reviews completed 十天后decision in progress 两天后reject 拒绝的很干脆（伤心流泪猫猫头.jpg）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=519d8123215, createdName=ms2000000001186103, createdTime=Wed Oct 05 17:30:21 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1225100, encodeId=2e8412251000f, content=with editor是还没找到编辑呢吗？要多久啊，我这一周多了还没信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Tue Jun 07 23:40:09 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207583, encodeId=c1e9120e583f8, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：with editor一周多了，是不是投搞时候要选择一个编辑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Thu Mar 31 16:38:30 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193646, encodeId=95b5119364659, content=2月10号投稿，2月14号with editor,2月14号当天decision in process，中间没有 undrer review，是不是要被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375f6502182, createdName=ms1000000321963424, createdTime=Tue Feb 15 16:29:09 CST 2022, time=2022-02-15, status=1, ipAttribution=)]

2022-12-11 ms3000001872426513 来自河南省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤免疫
经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！

3 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：癌症;肿瘤;临床 经验分享：做的自己的测序数据➕公共数据库的分析， Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20，一周了还在编辑手里，急死了，(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157084, encodeId=ab09215e0844c, content=9月5日投稿， 9月8日 w i t h e d i t o r，当天 d e c i s i o n i n p r o c e s s 是不是直接被拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fade2534638, createdName=lieju2, createdTime=Mon Sep 11 08:44:14 CST 2023, time=2023-09-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=946016, encodeId=6bad94601674, content=审稿速度:2.0 经验分享：2021-01-29提交 2021-02-01 with editor 2021-03-01 decision in process 中间没有 undrer review，网上询问网友的结果是多半悲剧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/c43b318bec32425a9676f05399c0cd55/11d43e45561e4c748a631fc4a900607e.jpg, createdBy=5bff5319966, createdName=mmz2101863, createdTime=Sat Mar 06 19:31:45 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：投稿2天后with editor，26天后decision in prosess，大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2114665, encodeId=31b021146654c, content=偏重的研究方向：肿瘤化疗 经验分享：当天with editor，两周多后直接Decision in Process，感觉要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Wed Feb 15 01:50:22 CST 2023, time=2023-02-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2091936, encodeId=f0a2209193669, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：投稿当天under review 一个月reviews completed 十天后decision in progress 两天后reject 拒绝的很干脆（伤心流泪猫猫头.jpg）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=519d8123215, createdName=ms2000000001186103, createdTime=Wed Oct 05 17:30:21 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1225100, encodeId=2e8412251000f, content=with editor是还没找到编辑呢吗？要多久啊，我这一周多了还没信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Tue Jun 07 23:40:09 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207583, encodeId=c1e9120e583f8, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：with editor一周多了，是不是投搞时候要选择一个编辑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Thu Mar 31 16:38:30 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193646, encodeId=95b5119364659, content=2月10号投稿，2月14号with editor,2月14号当天decision in process，中间没有 undrer review，是不是要被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375f6502182, createdName=ms1000000321963424, createdTime=Tue Feb 15 16:29:09 CST 2022, time=2022-02-15, status=1, ipAttribution=)]

2022-06-07 ms6000001244498457

with editor是还没找到编辑呢吗？要多久啊，我这一周多了还没信。

68 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：癌症;肿瘤;临床 经验分享：做的自己的测序数据➕公共数据库的分析， Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20，一周了还在编辑手里，急死了，(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157084, encodeId=ab09215e0844c, content=9月5日投稿， 9月8日 w i t h e d i t o r，当天 d e c i s i o n i n p r o c e s s 是不是直接被拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fade2534638, createdName=lieju2, createdTime=Mon Sep 11 08:44:14 CST 2023, time=2023-09-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=946016, encodeId=6bad94601674, content=审稿速度:2.0 经验分享：2021-01-29提交 2021-02-01 with editor 2021-03-01 decision in process 中间没有 undrer review，网上询问网友的结果是多半悲剧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/c43b318bec32425a9676f05399c0cd55/11d43e45561e4c748a631fc4a900607e.jpg, createdBy=5bff5319966, createdName=mmz2101863, createdTime=Sat Mar 06 19:31:45 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：投稿2天后with editor，26天后decision in prosess，大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2114665, encodeId=31b021146654c, content=偏重的研究方向：肿瘤化疗 经验分享：当天with editor，两周多后直接Decision in Process，感觉要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Wed Feb 15 01:50:22 CST 2023, time=2023-02-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2091936, encodeId=f0a2209193669, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：投稿当天under review 一个月reviews completed 十天后decision in progress 两天后reject 拒绝的很干脆（伤心流泪猫猫头.jpg）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=519d8123215, createdName=ms2000000001186103, createdTime=Wed Oct 05 17:30:21 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1225100, encodeId=2e8412251000f, content=with editor是还没找到编辑呢吗？要多久啊，我这一周多了还没信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Tue Jun 07 23:40:09 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207583, encodeId=c1e9120e583f8, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：with editor一周多了，是不是投搞时候要选择一个编辑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Thu Mar 31 16:38:30 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193646, encodeId=95b5119364659, content=2月10号投稿，2月14号with editor,2月14号当天decision in process，中间没有 undrer review，是不是要被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375f6502182, createdName=ms1000000321963424, createdTime=Tue Feb 15 16:29:09 CST 2022, time=2022-02-15, status=1, ipAttribution=)]

2022-03-31 左手摸机

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤
经验分享：with editor一周多了，是不是投搞时候要选择一个编辑呢

64 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1195298, encodeId=82bd119529896, content=审稿速度:4.0 | 投稿命中率:25.0 偏重的研究方向：癌症;肿瘤;临床 经验分享：做的自己的测序数据➕公共数据库的分析， Feb 09-2022 initial data submitted Feb 14-2022 with editor 到今天Feb 20，一周了还在编辑手里，急死了，(¬_¬)后续进展会在评论里持续更新 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210909/7146f1426c1e49bbb98d94637759e71f/7d17fd3269ca410d895702092f504459.jpg, createdBy=ac155115075, createdName=一只虫虫, createdTime=Sun Feb 20 10:50:27 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2157084, encodeId=ab09215e0844c, content=9月5日投稿， 9月8日 w i t h e d i t o r，当天 d e c i s i o n i n p r o c e s s 是不是直接被拒了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fade2534638, createdName=lieju2, createdTime=Mon Sep 11 08:44:14 CST 2023, time=2023-09-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=946016, encodeId=6bad94601674, content=审稿速度:2.0 经验分享：2021-01-29提交 2021-02-01 with editor 2021-03-01 decision in process 中间没有 undrer review，网上询问网友的结果是多半悲剧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210306/c43b318bec32425a9676f05399c0cd55/11d43e45561e4c748a631fc4a900607e.jpg, createdBy=5bff5319966, createdName=mmz2101863, createdTime=Sat Mar 06 19:31:45 CST 2021, time=2021-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2150275, encodeId=133c21502e56e, content=审稿速度:6.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：投稿2天后with editor，26天后decision in prosess，大概率是凉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9288721661, createdName=ms7000000964395486, createdTime=Fri Jul 28 18:05:04 CST 2023, time=2023-07-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2114665, encodeId=31b021146654c, content=偏重的研究方向：肿瘤化疗 经验分享：当天with editor，两周多后直接Decision in Process，感觉要凉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=149b8330439, createdName=ms5000000259255905, createdTime=Wed Feb 15 01:50:22 CST 2023, time=2023-02-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2091936, encodeId=f0a2209193669, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：投稿当天under review 一个月reviews completed 十天后decision in progress 两天后reject 拒绝的很干脆（伤心流泪猫猫头.jpg）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=519d8123215, createdName=ms2000000001186103, createdTime=Wed Oct 05 17:30:21 CST 2022, time=2022-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105348, encodeId=7306210534879, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤免疫 经验分享：写了一篇研究性质的letter,1000字左右，投稿后两天直接接收，只能用两个字形容：效率！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520f5425099, createdName=ms3000001872426513, createdTime=Sun Dec 11 11:52:23 CST 2022, time=2022-12-11, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1225100, encodeId=2e8412251000f, content=with editor是还没找到编辑呢吗？要多久啊，我这一周多了还没信。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f7d6548351, createdName=ms6000001244498457, createdTime=Tue Jun 07 23:40:09 CST 2022, time=2022-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207583, encodeId=c1e9120e583f8, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：with editor一周多了，是不是投搞时候要选择一个编辑呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb125463318, createdName=左手摸机, createdTime=Thu Mar 31 16:38:30 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193646, encodeId=95b5119364659, content=2月10号投稿，2月14号with editor,2月14号当天decision in process，中间没有 undrer review，是不是要被拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=375f6502182, createdName=ms1000000321963424, createdTime=Tue Feb 15 16:29:09 CST 2022, time=2022-02-15, status=1, ipAttribution=)]

2022-02-15 ms1000000321963424

2月10号投稿，2月14号with editor,2月14号当天decision in process，中间没有 undrer review，是不是要被拒稿了

86 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务